We believe there is minimal cause for concern with LLY stock, which makes it attractive but highly sensitive to adverse ...

Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, launched a new advertising campaign on Friday warning patients about off-brand versions of its treatments, saying “they put ...

Medical bottles and syringe are seen with Eli Lilly and Company logo displayed on a screen in the background in this illustration photo taken in Krakow, Poland on November 10, 2022. The weight ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing reliance on foreign supply chains.